Vitura Health Ltd (ASX: VIT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Vitura Health Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Vitura Health Ltd (ASX: VIT)
Latest News

Share Gainers
3 ASX All Ordinaries shares surging more than 10% today

Share Gainers
Why Audinate, Endeavour, IAG, and Vitura Health shares are charging higher

Share Gainers
Why Beach, Coles, Cronos Australia, and Woolworths shares are pushing higher

Share Fallers
Why Cronos Australia, Pilbara Minerals, Sayona Mining, and Strike Energy are dropping

Share Fallers
Why Cronos Australia, Mesoblast, Sims, and WAM Research are dropping

Cannabis Shares
ASX cannabis share Cronos has soared 80% in a month. What's going on?

Share Gainers
Why Air New Zealand, Cronos, Soul Patts, and Viva Energy shares are pushing higher

Broker Notes
Bell Potter slaps buy rating on this profitable, dividend-paying ASX cannabis share

Earnings Results
Guess which company just became the first ASX cannabis share to pay a dividend

Cannabis Shares
Can ASX cannabis shares ever fully recover?

Earnings Results
Guess which ASX cannabis share just rocketed 30%

Cannabis Shares
Green shoots or just weeds? The outlook for ASX cannabis shares in FY23
Dividend Payment History Data provided by Morningstar.
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
04 Sep 2023 | $0.0100 | 100.00% | Final | 28 Sep 2023 |
16 Sep 2022 | $0.0100 | 100.00% | Final | 11 Oct 2022 |
VIT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Vitura Health Ltd
Vitura Health Ltd. operates as a medicinal cannabis company. It engages in product and brand development, outsourced manufacturing and distribution for Australia and target export markets. The company was founded on September 27, 2018 and is headquartered in Melbourne, Australia.
VIT Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
07 Feb 2025 | $0.07 | $0.00 | 0.00% | 77,199 | $0.07 | $0.08 | $0.07 |
06 Feb 2025 | $0.07 | $0.00 | 0.00% | 222,294 | $0.07 | $0.08 | $0.07 |
05 Feb 2025 | $0.07 | $-0.01 | -12.66% | 115,236 | $0.08 | $0.08 | $0.07 |
04 Feb 2025 | $0.08 | $0.00 | 0.00% | 24,850 | $0.08 | $0.08 | $0.08 |
03 Feb 2025 | $0.08 | $0.00 | 0.00% | 55,483 | $0.08 | $0.08 | $0.08 |
31 Jan 2025 | $0.08 | $0.00 | 0.00% | 193,517 | $0.08 | $0.08 | $0.08 |
30 Jan 2025 | $0.08 | $0.00 | 0.00% | 82,162 | $0.08 | $0.08 | $0.08 |
29 Jan 2025 | $0.08 | $0.00 | 0.00% | 144,744 | $0.08 | $0.08 | $0.07 |
28 Jan 2025 | $0.08 | $-0.01 | -12.50% | 577,126 | $0.08 | $0.08 | $0.08 |
24 Jan 2025 | $0.08 | $0.00 | 0.00% | 25,195 | $0.08 | $0.08 | $0.08 |
23 Jan 2025 | $0.08 | $0.00 | 0.00% | 54,085 | $0.08 | $0.08 | $0.08 |
22 Jan 2025 | $0.08 | $0.00 | 0.00% | 460,660 | $0.08 | $0.09 | $0.08 |
21 Jan 2025 | $0.08 | $0.00 | 0.00% | 680,656 | $0.08 | $0.08 | $0.08 |
20 Jan 2025 | $0.08 | $0.00 | 0.00% | 145,617 | $0.08 | $0.08 | $0.08 |
17 Jan 2025 | $0.08 | $0.00 | 0.00% | 292,166 | $0.08 | $0.08 | $0.08 |
16 Jan 2025 | $0.08 | $0.00 | 0.00% | 9,264 | $0.08 | $0.08 | $0.08 |
15 Jan 2025 | $0.08 | $0.00 | 0.00% | 61,526 | $0.08 | $0.08 | $0.08 |
14 Jan 2025 | $0.08 | $0.00 | 0.00% | 74,699 | $0.08 | $0.08 | $0.08 |
13 Jan 2025 | $0.08 | $0.00 | 0.00% | 9,299 | $0.08 | $0.08 | $0.08 |
10 Jan 2025 | $0.08 | $-0.01 | -11.49% | 561,729 | $0.08 | $0.08 | $0.08 |
09 Jan 2025 | $0.09 | $0.00 | 0.00% | 1,000 | $0.09 | $0.09 | $0.09 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
04 Sep 2024 | Robert Iervasi | Buy | 179,200 | $15,076 |
On-market trade.
|
30 May 2024 | Jenelle Frewen | Buy | 190,740 | $25,944 |
On-market trade.
|
28 May 2024 | Robert Iervasi | Buy | 280,250 | $24,795 |
On-market trade.
|
29 Apr 2024 | Guy Headley | Sell | 3,500,000 | $385,000 |
On-market trade.
|
23 Apr 2024 | Guy Headley | Sell | 10,000,000 | $1,100,000 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Shane Francis Tanner | Non-Executive Director | Oct 2018 |
Mr Tanner is an Executive and Director with a record over many years of operating in multiple industries and markets. Shane was formerly CFO of an ASX Top 25 company (Mayne Nickless Limited (ASX: MAY)), as well as the inaugural CEO of Symbion Health (formerly known as Mayne Nickless Diagnostic Services). He also played a role in the float of Optus Communications. Over the past 20 years, Shane has been involved with multiple successful IPOs (including Vitura in November 2019) and many large-scale mergers and acquisitions. He has served as either the Chair or Non-Executive Director on more than ten public company boards and many other private companies.
|
Ms Rebecca Jayne Wilson | Non-Executive Director | Nov 2024 |
Ms Wilson is a company director with private, ASX-listed and not for-profit organisations. She is currently the Non-Executive Chair of global healthcare technology company, Alcidion Limited (ASX: ALC), and Ai-enabled technology platform LBT Innovations (ASX: LBT), and a Non-Executive Director of ASX listed enterprise technology company Hansen Technologies (ASX: HSN), and not-for-profit Tomisich Foundation. In an executive career spanning 25 years, she held global leadership roles in marketing communication, brand positioning, investor relations, capital management, and corporate affairs. She has expertise in ESG, complex stakeholder communication, brand awareness, issues, crisis and risk management, transactions, and investor relations. She has experience leading companies in commercial activation phases working with CEOs as both an advisor and Non-Executive Director. Shes worked as a NED since 2017, including Committee representation on Remuneration and Nominations (including as Chair), M&A, ESG, and Audit and Risk.
|
Mr Robert Iervasi | Non-Executive ChairmanNon-Executive Director | Feb 2024 |
Mr Iervasi as the former Group CEO and Director of Asahi Beverages, Robert led a diversified consumer products / FMCG business with more than $5 billion in annual revenue and over 5,000 employees, including a manufacturing footprint. Prior to this, he served as the Group COO and CFO and General Counsel of Asahi for over eight years, managing Finance, Shared Business Services, Legal, Risk Strategy and Information Technology, as well Sales, Marketing, Supply Chain and Science and Innovation. Robert has successfully driven profitability and growth across multiple categories, brands and channels. In 2020, he identified and executed the acquisition by Asahi of Carlton & United Breweries. Robert brings experience and expertise in governance, finance, law, and innovation to Vitura.
|
Mr Gerard Paul Fogarty | Non-Executive Director | Nov 2024 |
Mr Fogarty is a non-executive director and CEO.His board and executive roles have a variety of sectors, including national security, industrial relations regulation, work health and safety regulation, compensation and rehabilitation regulation, medical research, human performance research and health insurance. His background spans entities, including statutory authorities, joint ventures, industry bodies, not-for-profits and advisory boards. He was most recently a CEO of a private health insurer.
|
Mr Daniel Francis Birch | Non-Executive Director | Nov 2024 |
Mr Birch has 20 years experience advising clients across a range of industries.
|
Mr Thomas Godfrey Howitt | Chief Financial OfficerCompany SecretaryInterim CEO | Aug 2020 |
-
|
Mr Geoff Cockerill | Chief Executive Officer | Nov 2024 |
-
|
Geoff Cockerill | Chief Executive Officer |
-
|
|
Thomas Godfrey Howitt | Chief Financial OfficerCompany SecretaryInterim CEO |
-
|
|
Nicola M. Swarbrick | Chief Operating Officer |
-
|
|
Ryan Tattle | Chief Revenue Officer |
-
|
|
Stefan Schmidt | Chief Technology Officer |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Elizabeth Sarah Jansen <Stanford Investment Trust> | 118,757,765 | 20.62% |
Guy Rothwell Headley | 95,548,772 | 16.59% |
Cronos Global Holdings Inc. | 55,176,065 | 9.58% |
Matua Hasyo Charlie Jansen <Whanau Family Trust> | 44,117,428 | 7.66% |
NewSouthern Investment Holdings 1 Pty Ltd <NewSouthern Investment Trust 1> | 21,000,000 | 3.65% |
NewSouthern Investment Holdings A Pty Ltd | 18,441,007 | 3.20% |
Citicorp Nominees Pty Limited | 13,225,910 | 2.31% |
HSBC Custody Nominees (Australia) Limited | 11,284,879 | 1.96% |
Ashanna Pty Ltd | 10,766,897 | 1.87% |
Melbourne Securities Corporation Limited <BV1 Fund A/C> | 9,000,000 | 1.56% |
Stone Group Pty Ltd <Stone Children A/C> | 6,377,765 | 1.11% |
UBS Nominees Pty Ltd | 5,833,174 | 1.01% |
EJ Watson (Medical) Pty Ltd <The EJ Watson Med S/F A/C> | 5,000,000 | 0.87% |
Jessimine Jansen | 4,253,379 | 0.74% |
Hektares SG Holdings Pte Ltd | 4,050,940 | 0.70% |
Daniel Francis Birch <BES A/C> | 3,766,498 | 0.65% |
Craig Graeme Chapman <Nampac Discretionary A/C> | 3,500,000 | 0.61% |
Ryan Tattle | 3,451,189 | 0.60% |
Robert Charles Hussey | 3,000,000 | 0.52% |
William David Copland and Susan Mary Copland David Copland Super fund A/C> | 2,484,000 | 0.43% |